CORRIGAN MARK 4
4 · Wave Life Sciences Ltd. · Filed Sep 6, 2019
Insider Transaction Report
Form 4
CORRIGAN MARK
Director
Transactions
- Award
Share Option (right to buy)
2019-09-04+21,000→ 21,000 totalExercise: $21.03Exp: 2024-09-04→ Ordinary Shares (21,000 underlying)
Footnotes (1)
- [F1]The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 25% of the shares on September 4, 2020 and the remainder vests quarterly thereafter until September 4, 2023.